Study details
Enrolling now
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
Rachel Miller
NCT IDNCT03089554ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
93
Study length
about 9.1 years
Ages
18+
Locations
1 site in KY
What this study is about
Researchers are testing a treatment based on genomic analysis results to see if it helps people with cancer live longer. The trial will last for 3306 days and involve approximately 93 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Therapeutic Intervention
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Progression Free Survival
Body systems
Oncology